Global Head Lice Infestation Treatment Market Growth 2025-2031

Publication ID:

LPI04253150

Publication Date:

April 28, 2025

Pages:

112

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Head Lice Infestation Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Head lice are small, wingless, blood-sucking insects that attack the hair. They feed on the blood of your scalp, which causes irritation or sometimes large pimples on the head. The male lice are much larger compared to the female lice. Head lice are transmissible if you get infected with head lice. Head lice are characterized by symptoms such as severe itching, tingling sensation when the hair moves, and sores on the scalp, neck, and shoulders. Head lice infestation is caused by poor personal hygiene. Head lice can be treated with over-the-counter drugs and prescribed drugs. There are many treatment options available to get rid of head lice, but most treatments need to be used twice or more. The second treatment takes place after a week to kill any newly hatched nits.
In North America and Europe, Head Lice Infestation Treatment key players include Stada Arzneimittel, Reckitt Benckier, Oystershell Consumer Health, Prestige Brands, Perrigo, etc. Top five manufacturers hold a share about 60%.
Europe is the larger market, with a share over 55%, followed by North America , which has a share over 40%.
In terms of product, OTC is the largest segment, with a share over 95%. And in terms of application, the largest application is children, followed by adults.
The 鈥淗ead Lice Infestation Treatment Industry Forecast鈥� looks at past sales and reviews total world Head Lice Infestation Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Head Lice Infestation Treatment sales for 2025 through 2031. With Head Lice Infestation Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Head Lice Infestation Treatment industry.
This Insight Report provides a comprehensive analysis of the global Head Lice Infestation Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Head Lice Infestation Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Head Lice Infestation Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Head Lice Infestation Treatment and breaks down the forecast by Type, by End User, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Head Lice Infestation Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Head Lice Infestation Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
OTC
Prescription
Segmentation by End User:
Children
Adults
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Arbor Pharmaceuticals
Stada Arzneimittel
Prestige Brands
Oystershell Consumer Health
Reckitt Benckier
Perrigo
ParaPRO
TecLabs
Alliance Pharma Inc.
Nuvo Pharmaceuticals
Medexus Pharmaceuticals
Logic Product Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Head Lice Infestation Treatment market?
What factors are driving Head Lice Infestation Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Head Lice Infestation Treatment market opportunities vary by end market size?
How does Head Lice Infestation Treatment break out by Type, by End User?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Head Lice Infestation Treatment Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Head Lice Infestation Treatment by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Head Lice Infestation Treatment by Country/Region, 2020, 2024 & 2031
2.2 Head Lice Infestation Treatment Segment by Type
2.2.1 OTC
2.2.2 Prescription
2.3 Head Lice Infestation Treatment Sales by Type
2.3.1 Global Head Lice Infestation Treatment Sales Market Share by Type (2020-2025)
2.3.2 Global Head Lice Infestation Treatment Revenue and Market Share by Type (2020-2025)
2.3.3 Global Head Lice Infestation Treatment Sale Price by Type (2020-2025)
2.4 Head Lice Infestation Treatment Segment by End User
2.4.1 Children
2.4.2 Adults
2.5 Head Lice Infestation Treatment Sales by End User
2.5.1 Global Head Lice Infestation Treatment Sale Market Share by End User (2020-2025)
2.5.2 Global Head Lice Infestation Treatment Revenue and Market Share by End User (2020-2025)
2.5.3 Global Head Lice Infestation Treatment Sale Price by End User (2020-2025)
3 Global by Company
3.1 Global Head Lice Infestation Treatment Breakdown Data by Company
3.1.1 Global Head Lice Infestation Treatment Annual Sales by Company (2020-2025)
3.1.2 Global Head Lice Infestation Treatment Sales Market Share by Company (2020-2025)
3.2 Global Head Lice Infestation Treatment Annual Revenue by Company (2020-2025)
3.2.1 Global Head Lice Infestation Treatment Revenue by Company (2020-2025)
3.2.2 Global Head Lice Infestation Treatment Revenue Market Share by Company (2020-2025)
3.3 Global Head Lice Infestation Treatment Sale Price by Company
3.4 Key Manufacturers Head Lice Infestation Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Head Lice Infestation Treatment Product Location Distribution
3.4.2 Players Head Lice Infestation Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Head Lice Infestation Treatment by Geographic Region
4.1 World Historic Head Lice Infestation Treatment Market Size by Geographic Region (2020-2025)
4.1.1 Global Head Lice Infestation Treatment Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Head Lice Infestation Treatment Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Head Lice Infestation Treatment Market Size by Country/Region (2020-2025)
4.2.1 Global Head Lice Infestation Treatment Annual Sales by Country/Region (2020-2025)
4.2.2 Global Head Lice Infestation Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Head Lice Infestation Treatment Sales Growth
4.4 APAC Head Lice Infestation Treatment Sales Growth
4.5 Europe Head Lice Infestation Treatment Sales Growth
4.6 Middle East & Africa Head Lice Infestation Treatment Sales Growth
5 Americas
5.1 Americas Head Lice Infestation Treatment Sales by Country
5.1.1 Americas Head Lice Infestation Treatment Sales by Country (2020-2025)
5.1.2 Americas Head Lice Infestation Treatment Revenue by Country (2020-2025)
5.2 Americas Head Lice Infestation Treatment Sales by Type (2020-2025)
5.3 Americas Head Lice Infestation Treatment Sales by End User (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Head Lice Infestation Treatment Sales by Region
6.1.1 APAC Head Lice Infestation Treatment Sales by Region (2020-2025)
6.1.2 APAC Head Lice Infestation Treatment Revenue by Region (2020-2025)
6.2 APAC Head Lice Infestation Treatment Sales by Type (2020-2025)
6.3 APAC Head Lice Infestation Treatment Sales by End User (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Head Lice Infestation Treatment by Country
7.1.1 Europe Head Lice Infestation Treatment Sales by Country (2020-2025)
7.1.2 Europe Head Lice Infestation Treatment Revenue by Country (2020-2025)
7.2 Europe Head Lice Infestation Treatment Sales by Type (2020-2025)
7.3 Europe Head Lice Infestation Treatment Sales by End User (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Head Lice Infestation Treatment by Country
8.1.1 Middle East & Africa Head Lice Infestation Treatment Sales by Country (2020-2025)
8.1.2 Middle East & Africa Head Lice Infestation Treatment Revenue by Country (2020-2025)
8.2 Middle East & Africa Head Lice Infestation Treatment Sales by Type (2020-2025)
8.3 Middle East & Africa Head Lice Infestation Treatment Sales by End User (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Head Lice Infestation Treatment
10.3 Manufacturing Process Analysis of Head Lice Infestation Treatment
10.4 Industry Chain Structure of Head Lice Infestation Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Head Lice Infestation Treatment Distributors
11.3 Head Lice Infestation Treatment Customer
12 World Forecast Review for Head Lice Infestation Treatment by Geographic Region
12.1 Global Head Lice Infestation Treatment Market Size Forecast by Region
12.1.1 Global Head Lice Infestation Treatment Forecast by Region (2026-2031)
12.1.2 Global Head Lice Infestation Treatment Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Head Lice Infestation Treatment Forecast by Type (2026-2031)
12.7 Global Head Lice Infestation Treatment Forecast by End User (2026-2031)
13 Key Players Analysis
13.1 Arbor Pharmaceuticals
13.1.1 Arbor Pharmaceuticals Company Information
13.1.2 Arbor Pharmaceuticals Head Lice Infestation Treatment Product Portfolios and Specifications
13.1.3 Arbor Pharmaceuticals Head Lice Infestation Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Arbor Pharmaceuticals Main Business Overview
13.1.5 Arbor Pharmaceuticals Latest Developments
13.2 Stada Arzneimittel
13.2.1 Stada Arzneimittel Company Information
13.2.2 Stada Arzneimittel Head Lice Infestation Treatment Product Portfolios and Specifications
13.2.3 Stada Arzneimittel Head Lice Infestation Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Stada Arzneimittel Main Business Overview
13.2.5 Stada Arzneimittel Latest Developments
13.3 Prestige Brands
13.3.1 Prestige Brands Company Information
13.3.2 Prestige Brands Head Lice Infestation Treatment Product Portfolios and Specifications
13.3.3 Prestige Brands Head Lice Infestation Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Prestige Brands Main Business Overview
13.3.5 Prestige Brands Latest Developments
13.4 Oystershell Consumer Health
13.4.1 Oystershell Consumer Health Company Information
13.4.2 Oystershell Consumer Health Head Lice Infestation Treatment Product Portfolios and Specifications
13.4.3 Oystershell Consumer Health Head Lice Infestation Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Oystershell Consumer Health Main Business Overview
13.4.5 Oystershell Consumer Health Latest Developments
13.5 Reckitt Benckier
13.5.1 Reckitt Benckier Company Information
13.5.2 Reckitt Benckier Head Lice Infestation Treatment Product Portfolios and Specifications
13.5.3 Reckitt Benckier Head Lice Infestation Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Reckitt Benckier Main Business Overview
13.5.5 Reckitt Benckier Latest Developments
13.6 Perrigo
13.6.1 Perrigo Company Information
13.6.2 Perrigo Head Lice Infestation Treatment Product Portfolios and Specifications
13.6.3 Perrigo Head Lice Infestation Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Perrigo Main Business Overview
13.6.5 Perrigo Latest Developments
13.7 ParaPRO
13.7.1 ParaPRO Company Information
13.7.2 ParaPRO Head Lice Infestation Treatment Product Portfolios and Specifications
13.7.3 ParaPRO Head Lice Infestation Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 ParaPRO Main Business Overview
13.7.5 ParaPRO Latest Developments
13.8 TecLabs
13.8.1 TecLabs Company Information
13.8.2 TecLabs Head Lice Infestation Treatment Product Portfolios and Specifications
13.8.3 TecLabs Head Lice Infestation Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 TecLabs Main Business Overview
13.8.5 TecLabs Latest Developments
13.9 Alliance Pharma Inc.
13.9.1 Alliance Pharma Inc. Company Information
13.9.2 Alliance Pharma Inc. Head Lice Infestation Treatment Product Portfolios and Specifications
13.9.3 Alliance Pharma Inc. Head Lice Infestation Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Alliance Pharma Inc. Main Business Overview
13.9.5 Alliance Pharma Inc. Latest Developments
13.10 Nuvo Pharmaceuticals
13.10.1 Nuvo Pharmaceuticals Company Information
13.10.2 Nuvo Pharmaceuticals Head Lice Infestation Treatment Product Portfolios and Specifications
13.10.3 Nuvo Pharmaceuticals Head Lice Infestation Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Nuvo Pharmaceuticals Main Business Overview
13.10.5 Nuvo Pharmaceuticals Latest Developments
13.11 Medexus Pharmaceuticals
13.11.1 Medexus Pharmaceuticals Company Information
13.11.2 Medexus Pharmaceuticals Head Lice Infestation Treatment Product Portfolios and Specifications
13.11.3 Medexus Pharmaceuticals Head Lice Infestation Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Medexus Pharmaceuticals Main Business Overview
13.11.5 Medexus Pharmaceuticals Latest Developments
13.12 Logic Product Group
13.12.1 Logic Product Group Company Information
13.12.2 Logic Product Group Head Lice Infestation Treatment Product Portfolios and Specifications
13.12.3 Logic Product Group Head Lice Infestation Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Logic Product Group Main Business Overview
13.12.5 Logic Product Group Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂